Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5DTS

Fragments bound to the OXA-48 beta-lactamase: Compound 2

Summary for 5DTS
Entry DOI10.2210/pdb5dts/pdb
Related5DVA
DescriptorBeta-lactamase, 3-(pyridin-3-yl)benzoic acid, CHLORIDE ION, ... (4 entities in total)
Functional Keywordsinhibitor, complex, fragment, lactamase, hydrolase
Biological sourceKlebsiella pneumoniae
Total number of polymer chains4
Total formula weight114059.84
Authors
Lund, B.A.,Christopeit, T.,Leiros, H.-K.S. (deposition date: 2015-09-18, release date: 2016-05-25, Last modification date: 2024-01-10)
Primary citationLund, B.A.,Christopeit, T.,Guttormsen, Y.,Bayer, A.,Leiros, H.K.
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening.
J.Med.Chem., 59:5542-5554, 2016
Cited by
PubMed Abstract: The spread of antibiotic resistant bacteria is a global threat that shakes the foundations of modern healthcare. β-Lactamases are enzymes that confer resistance to β-lactam antibiotics in bacteria, and there is a critical need for new inhibitors of these enzymes for combination therapy together with an antibiotic. With this in mind, we have screened a library of 490 fragments to identify starting points for the development of new inhibitors of the class D β-lactamase oxacillinase-48 (OXA-48) through surface plasmon resonance (SPR), dose-rate inhibition assays, and X-ray crystallography. Furthermore, we have uncovered structure-activity relationships and used alternate conformations from a crystallographic structure to grow a fragment into a more potent compound with a KD of 50 μM and an IC50 of 18 μM.
PubMed: 27165692
DOI: 10.1021/acs.jmedchem.6b00660
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.94015871727 Å)
Structure validation

227111

数据于2024-11-06公开中

PDB statisticsPDBj update infoContact PDBjnumon